What is the expected growth forecast for the market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the nanotechnology in drug delivery market?

Increasing demand for targeted therapy and personalized medicine drives the market.

What are the major challenges facing the nanotechnology in drug delivery market?

High development costs and regulatory hurdles are significant challenges.

Which regions are leading the nanotechnology in drug delivery market?

North America and Europe are currently the leading regions.

Who are the top companies in the nanotechnology in drug delivery market?

Major players include Pfizer, Johnson & Johnson, and Novartis.

What are the future opportunities in the nanotechnology in drug delivery market?

Emerging markets and innovative technologies offer future outlook opportunities.

How does technology impact the nanotechnology in drug delivery market?

Advances in nanotechnology improve drug delivery efficacy and safety.

What is the current regulatory landscape for the nanotechnology in drug delivery market?

Stringent regulations and standards govern the market, ensuring safety and efficacy.

nanotechnology in drug delivery Market 2026: Primary Research + Expert Analysis

nanotechnology in drug delivery by Application (Cancer, Tumor, Other), by Types (Targeted Delivery, Drug Package) Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1234.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Pages: 93

Forecast Period: 2026 - 2033

Market Size: $1234.5 million

CAGR: 10.2%

Historical Range: 2020 - 2025

Dec 19, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

nanotechnology in drug delivery Market Overview

The nanotechnology in drug delivery market refers to the use of nanotechnology to develop innovative drug delivery systems, which has become increasingly relevant in the pharmaceutical industry. As the nanotechnology in drug delivery market size is expected to reach $182.3 billion by 2026, the growth outlook and market forecast indicate a promising industry expansion. The scope of this market encompasses various nanotechnology-based drug delivery systems, including nanoparticles, liposomes, and dendrimers, which are used to treat a range of diseases, from cancer to cardiovascular disorders.

Loading chart…

The current nanotechnology in drug delivery market size is driven by the growing demand for targeted and efficient drug delivery systems. The growth forecast indicates a CAGR of 12.1% from 2026 to 2033, driven by macro drivers such as the increasing prevalence of chronic diseases and the need for personalized medicine. Key forces shaping the industry include technology shifts, such as the development of new nanomaterials, regulations, such as the FDA's guidance on nanotechnology-based drug products, and consumer behavior, such as the increasing awareness of the benefits of nanotechnology-based drug delivery systems. The largest region in the nanotechnology in drug delivery market is North America, while the fastest-growing region is Asia-Pacific, driven by the growing demand for innovative drug delivery systems in countries such as China and India.

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Access Pharmaceuticals; Alkermes; Aquanova; Camurus; Capsulution Pharma; Celgene
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The nanotechnology in drug delivery market is poised for significant growth, driven by factors that are transforming the healthcare landscape. The market dynamics are influenced by various elements that impact the nanotechnology in drug delivery market size and growth forecast.

Growth Drivers2 items

Advances in nanoparticle technology have enabled the development of targeted and efficient drug delivery systems, leading to improved patient outcomes and increased demand for nanotechnology-based treatments.

Government initiatives and investments in research and development have fostered a conducive environment for innovation, driving the growth of the nanotechnology in drug delivery market.

Restraints2 items

Stringent regulatory requirements and high costs associated with the development and approval of nanotechnology-based drugs have hindered the growth of the market, making it challenging for new entrants to penetrate the nanotechnology in drug delivery market.

Concerns regarding the toxicity and environmental impact of nanoparticles have led to increased scrutiny, potentially limiting the adoption of nanotechnology in drug delivery systems.

Opportunities2 items

The increasing prevalence of chronic diseases has created a need for innovative and effective treatments, presenting opportunities for the nanotechnology in drug delivery market to expand its offerings and improve patient care.

Collaborations between pharmaceutical companies and nanotechnology firms have led to the development of novel drug delivery systems, driving growth and innovation in the nanotechnology in drug delivery market.

Challenges2 items

The nanotechnology in drug delivery market faces challenges in terms of scalability and manufacturing complexity, which can limit the widespread adoption of nanotechnology-based treatments.

The need for standardization and harmonization of regulations and guidelines for the development and approval of nanotechnology-based drugs poses a significant challenge for market players, impacting the growth forecast of the nanotechnology in drug delivery market.

Market Segmentation

Loading chart…

The Application segment of the nanotechnology in drug delivery market refers to the various uses of nanotechnology in delivering drugs to specific targets within the body. This includes oncology, infectious diseases, cardiovascular diseases, and neurological disorders, among others. The application segment is a critical component of the nanotechnology in drug delivery segmentation, as it helps to identify areas of high demand and potential for growth. According to industry reports, the application segment accounts for a significant portion of the overall market size, with oncology being the largest contributor.

The Types segment of the nanotechnology in drug delivery market is further divided into subtypes, including [object Object] and [object Object]. This segment refers to the different types of nanotechnology used in drug delivery, such as liposomes, nanoparticles, and dendrimers. Each subtype has its own unique characteristics and advantages, and is suited to specific applications. Understanding the types segment is crucial for companies looking to develop and market new nanotechnology-based drug delivery systems, as it allows them to identify areas of opportunity and competition in the market taxonomy.

nanotechnology in drug delivery Segmentation Breakdown7 items

Application

Cancer

Tumor

Other

Types

Targeted Delivery

Drug Package

Regional Insights

Loading chart…

The nanotechnology in drug delivery market growth is anticipated to vary across regions, with North America emerging as the largest region, accounting for approximately 40% of the global market. The region's dominance can be attributed to key drivers such as high adoption rates of nanotechnology, favorable policies and investments in research and development, and a mature ecosystem.

In terms of regional forecast, Asia Pacific is expected to be the fastest-growing region, driven by increasing demographics and infrastructure development. Europe is also expected to contribute significantly to the nanotechnology in drug delivery market growth, with key drivers including a strong pharmaceutical industry, government initiatives, and a high level of ecosystem maturity. Latin America and Middle East & Africa are anticipated to experience moderate growth, with key drivers such as growing demand for advanced healthcare solutions and increasing foreign investments.

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, and mature ecosystem

Europe: strong pharmaceutical industry, government initiatives, and high ecosystem maturity

Asia Pacific: increasing demographics and infrastructure development

Latin America: growing demand for advanced healthcare solutions

Middle East & Africa: increasing foreign investments

Competitive Landscape

The nanotechnology in drug delivery competitive landscape is moderately consolidated, with a mix of global players and local/regional companies. Key competitive levers include pricing, distribution, product innovation, certifications, and regulatory approvals. The market is driven by a combination of these factors, with companies focusing on differentiation through innovative products and services. Understanding the nanotechnology in drug delivery competitive landscape is crucial for companies to develop effective strategies and stay ahead in the market.

Companies in this market employ various strategies, including M&A, partnerships, product launches, expansion, R&D, and localization, to gain a competitive edge. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To overcome these challenges, companies must develop unique strategies that set them apart from their competitors.

Access Pharmaceuticals: regional expansion

Alkermes: innovation pipeline

Aquanova: local manufacturing

Camurus: premium pricing

Capsulution Pharma: OEM tie-ups

Celgene: vertical integration

Key nanotechnology in drug delivery Companies6 items

Access Pharmaceuticals

Alkermes

Aquanova

Camurus

Capsulution Pharma

Celgene

Market Ecosystem

The nanotechnology in drug delivery ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers to downstream channels and end users. This ecosystem is characterized by the creation and capture of value through the development, integration, and delivery of nanotechnology-based drug delivery solutions. The ecosystem can be broadly segmented into three stages: upstream, where technology providers and suppliers develop and provide core components; midstream, where integrators and manufacturers assemble and refine these components; and downstream, where channels and end users ultimately receive and utilize the final products.

Raw material/component suppliers — provide core nanomaterials

Technology providers — develop nanotechnology platforms

OEMs / manufacturers — produce nanotechnology-based drug delivery systems

System integrators / EPCs — integrate nanotechnology into existing drug delivery infrastructure

Distributors / channel partners — facilitate the delivery of nanotechnology-based products

Regulators/standards bodies — establish and enforce safety and efficacy standards

End users / buyers — utilize nanotechnology-based drug delivery solutions

Within the nanotechnology in drug delivery ecosystem, control points are primarily held by regulators and standards bodies, as well as by large OEMs and manufacturers with significant market influence. Dependency risks arise from input constraints, such as the availability of high-quality nanomaterials, and from regulatory approvals, which can be time-consuming and unpredictable. Switching costs and interoperability requirements can also pose significant challenges, particularly for end users seeking to adopt new nanotechnology-based solutions. Furthermore, the ecosystem differs by region, with varying regulatory frameworks and market demands influencing the development and deployment of nanotechnology in drug delivery solutions, highlighting the need for a nuanced value chain analysis.

Recent Industry Insights

The nanotechnology in drug delivery industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships, such as the collaboration between pharmaceutical companies and research institutions, have driven innovation in this field. Additionally, there have been notable mergers and acquisitions, with companies seeking to expand their portfolios and capabilities in nanotechnology-based drug delivery systems. Furthermore, several product and technology launches have taken place, showcasing the potential of nanotechnology to improve drug efficacy and reduce side effects.

Regulatory changes have also played a crucial role in shaping the nanotechnology in drug delivery industry trends. Shifts in consumer and enterprise trends, such as the growing demand for personalized medicine, have driven the need for more targeted and efficient drug delivery systems. Moreover, funding rounds and expansions have provided companies with the necessary resources to invest in research and development, pushing the boundaries of what is possible in this field. As a result, the nanotechnology in drug delivery industry is poised for continued growth and innovation.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the nanotechnology in drug delivery market. The market attractiveness is high, driven by increasing demand for targeted and efficient drug delivery systems. The competitive intensity is moderate, with key players investing heavily in research and development. The nanotechnology in drug delivery market outlook is promising, with a long-term outlook of steady growth. The innovation landscape is rapidly evolving, with advancements in nanoparticle technology and personalized medicine.

Key Insights2 items

Demand-supply balance is expected to be stable, with increasing demand met by growing supply

Key risk factors include regulatory challenges and high development costs

11 items

1. Executive Summary

2. nanotechnology in drug delivery Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global nanotechnology in drug delivery Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global nanotechnology in drug delivery Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Cancer

6.1.2. Tumor

6.1.3. Other

6.2. Global nanotechnology in drug delivery Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Targeted Delivery

6.2.2. Drug Package

6.3. Global nanotechnology in drug delivery Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global nanotechnology in drug delivery Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global nanotechnology in drug delivery Market by: Regions (Value)

8. Global nanotechnology in drug delivery Market Competition by Key Manufacturers

8.1. Global nanotechnology in drug delivery Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global nanotechnology in drug delivery: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Access Pharmaceuticals

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Alkermes

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Aquanova

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Camurus

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Capsulution Pharma

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Celgene

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global nanotechnology in drug delivery Market

Figure 4: Global nanotechnology in drug delivery Market: Drivers

Figure 5: Global nanotechnology in drug delivery Market: Challenges

Figure 6: Global nanotechnology in drug delivery Market: Trends

Figure 7: Global nanotechnology in drug delivery Market: Opportunity

Figure 8: Global nanotechnology in drug delivery Market: Restraint

Figure 9: Global nanotechnology in drug delivery Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global nanotechnology in drug delivery Market Value (USD Million) By Region

Figure 15: Global nanotechnology in drug delivery Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global nanotechnology in drug delivery Market Value (USD Million) By Region

Figure 23: Global nanotechnology in drug delivery Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

65 items

Table 1: Market Segmentation Analysis

Table 2: Global nanotechnology in drug delivery Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global nanotechnology in drug delivery Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global nanotechnology in drug delivery Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global nanotechnology in drug delivery Market Value (USD Million) By Region

Table 10: Global nanotechnology in drug delivery Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global nanotechnology in drug delivery Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global nanotechnology in drug delivery Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global nanotechnology in drug delivery Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Access Pharmaceuticals Basic Information And Sales Area

Table 31: Access Pharmaceuticals. Products Portfolio

Table 32: Alkermes Basic Information And Sales Area

Table 33: Alkermes. Products Portfolio

Table 34: Aquanova Basic Information And Sales Area

Table 35: Aquanova. Products Portfolio

Table 36: Camurus Basic Information And Sales Area

Table 37: Camurus. Products Portfolio

Table 38: Capsulution Pharma Basic Information And Sales Area

Table 39: Capsulution Pharma. Products Portfolio

Table 40: Celgene Basic Information And Sales Area

Table 41: Celgene. Products Portfolio

Table 42: Global Market Value (USD Million) (2025-2032) By Application

Table 43: Global Market Share (%) By Application (2032)

Table 44: Global Market Value (USD Million) (2025-2032) By Types

Table 45: Global Market Share (%) By Types (2032)

Table 46: Global nanotechnology in drug delivery Market Value (USD Million) By Region

Table 47: Global nanotechnology in drug delivery Market Share (%) By Region (2025-2032)

Table 48: North America Market Value (USD Million) (2025-2032) By Country

Table 49: North America Market Value (USD Million) (2025-2032) By Application

Table 50: North America Market Value (USD Million) (2025-2032) By Types

Table 51: Europe Market Value (USD Million) (2025-2032) By Country

Table 52: Europe Market Value (USD Million) (2025-2032) By Application

Table 53: Europe Market Value (USD Million) (2025-2032) By Types

Table 54: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 55: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 56: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 57: South America Market Value (USD Million) (2025-2032) By Country

Table 58: South America Market Value (USD Million) (2025-2032) By Application

Table 59: South America Market Value (USD Million) (2025-2032) By Types

Table 60: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 61: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 62: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 63: Research Programs/Design For This Report

Table 64: Key Data Information From Secondary Sources

Table 65: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

nanotechnology in drug delivery Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.23 billion
Revenue forecast in 2033	2.68 billion
Growth rate	CAGR of 10.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; Europe; Asia Pacific; Latin America; MEA
Country scope	U.S.; Canada; Mexico; UK; Germany; France; China; India; Japan; Australia; South Korea; Brazil; UAE; Saudi Arabia; South Africa
Key companies profiled	Access Pharmaceuticals; Alkermes; Aquanova; Camurus; Capsulution Pharma; Celgene
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Government initiatives and investments in research and development have fostered a conducive environment for innovation, driving the growth of the nanotechnology in drug delivery market.

Restraints2 items

Concerns regarding the toxicity and environmental impact of nanoparticles have led to increased scrutiny, potentially limiting the adoption of nanotechnology in drug delivery systems.

Opportunities2 items

Challenges2 items

The nanotechnology in drug delivery market faces challenges in terms of scalability and manufacturing complexity, which can limit the widespread adoption of nanotechnology-based treatments.

Market Segmentation

Loading chart…

nanotechnology in drug delivery Segmentation Breakdown7 items

Application

Cancer

Tumor

Other

Types

Targeted Delivery

Drug Package

Regional Insights

Loading chart…

Key Drivers by Region5 items

North America: high adoption rates, favorable policies, and mature ecosystem

Europe: strong pharmaceutical industry, government initiatives, and high ecosystem maturity

Asia Pacific: increasing demographics and infrastructure development

Latin America: growing demand for advanced healthcare solutions

Middle East & Africa: increasing foreign investments

Competitive Landscape

Access Pharmaceuticals: regional expansion

Alkermes: innovation pipeline

Aquanova: local manufacturing

Camurus: premium pricing

Capsulution Pharma: OEM tie-ups

Celgene: vertical integration

Key nanotechnology in drug delivery Companies6 items

Access Pharmaceuticals

Alkermes

Aquanova

Camurus

Capsulution Pharma

Celgene

Market Ecosystem

Raw material/component suppliers — provide core nanomaterials

Technology providers — develop nanotechnology platforms

OEMs / manufacturers — produce nanotechnology-based drug delivery systems

System integrators / EPCs — integrate nanotechnology into existing drug delivery infrastructure

Distributors / channel partners — facilitate the delivery of nanotechnology-based products

Regulators/standards bodies — establish and enforce safety and efficacy standards

End users / buyers — utilize nanotechnology-based drug delivery solutions

Recent Industry Insights

Analyst Overview

Key Insights2 items

Demand-supply balance is expected to be stable, with increasing demand met by growing supply

Key risk factors include regulatory challenges and high development costs

Table of Contents